The Third International Cancer lmmunotherapy Conference 2017 was staged in Germany, in particular in Mainz, one of Europe’s leading research centres for cancer immunotherapy. The conference co-chairperson and President of CIMT, Prof. em. Dr. Christoph Huber, summarized his impressions: “Junior scientists from all over the world presented the products of their research work in more than 500 outstanding abstracts”.
Taking place from September 6 to 9, 2017, the program was composed of two poster sessions, eleven plenary sessions with 55 discourses, a keynote lecture and an award lecture, the William B. Coley Lecture. Almost 1,500 physicians and researchers travelled to the Rheingoldhalle Congress Center Mainz from over 30 countries to present pioneering studies on the most recent findings in fighting cancer. Themed “Translating Science into Survival”, participants had their particular focus on therapies which strengthen immune defense against tumor-specific neoantigens and on the transfer of genetically-modified defense cells.
Read the full article on the Iceberg website, a partner of Boardroom.